Talphera (TLPH) Change in Inventory (2016 - 2023)
Talphera (TLPH) posted Change in Inventory of -$61000.0 for Q1 2023, down 119.24% on a QoQ basis from $317000.0 in Q4 2022, and down 7.02% year-over-year from -$65603.8 in Q1 2022.
Powered by 
Analysis
Talphera (TLPH) Change in Inventory (2016 - 2023) Analysis & Trends
Talphera has reported Change in Inventory for 8 years, with the latest figure at -$61000.0 in Q1 2023.
- On a quarterly basis, Change in Inventory fell 7.02% year-over-year to -$61000.0 in Q1 2023; TTM through Dec 2023 was -$61000.0, a 157.01% decrease from a year earlier, with the FY2023 full-year figure at -$61000.0, down 157.01% from the prior year.
- Change in Inventory was -$61000.0 for Q1 2023 at Talphera, down from $317000.0 in the prior quarter.
- The five-year high for Change in Inventory was $1.5 million in Q1 2019, with the low at -$457000.0 in Q3 2020.
- Average Change in Inventory over 5 years is $163294.1, with a median of -$38000.0 recorded in 2021.
- The sharpest annual moves came in 2019 and 2022: Change in Inventory soared 20650.0% in 2019, then slumped 278.95% in 2022.
- Over 5 years, Change in Inventory stood at $411000.0 in 2019, then sank by 154.26% to -$223000.0 in 2020, then jumped by 151.57% to $115000.0 in 2021, then soared by 175.65% to $317000.0 in 2022, then sank by 119.24% to -$61000.0 in 2023.
- The last three Change in Inventory figures came in at -$61000.0 (Q1 2023), $317000.0 (Q4 2022), and -$9000.0 (Q3 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 31.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 145.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 27.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 28.20 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 132.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -280,000.00 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -75.70 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Talphera | 92.90 Mn | 92.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | -61,000.00 |
| Dec 31, 2022 | 317,000.00 |
| Sep 30, 2022 | -9,000.00 |
| Jun 30, 2022 | -144,000.00 |
| Mar 31, 2022 | -57,000.00 |
| Dec 31, 2021 | 115,000.00 |
| Sep 30, 2021 | 323,000.00 |
| Jun 30, 2021 | -38,000.00 |
| Mar 31, 2021 | -105,000.00 |
| Dec 31, 2020 | -223,000.00 |
| Sep 30, 2020 | -457,000.00 |
| Jun 30, 2020 | -189,000.00 |
| Mar 31, 2020 | -88,000.00 |
| Dec 31, 2019 | 411,000.00 |
| Sep 30, 2019 | 991,000.00 |
| Jun 30, 2019 | 441,000.00 |
| Mar 31, 2019 | 1.55 Mn |
| Dec 31, 2018 | -2,000.00 |
| Sep 30, 2018 | 193,000.00 |
| Jun 30, 2018 | -3,000.00 |